Skip to main content
- Smaller Text | + Larger Text

FDA Approval of Medical Marijuana - Studies Explored by Experts

  • Synopsis: Published: 2014-06-04 - Experts to explore safety data required for Institutional Review Board and FDA approval of human Phase I, II, III studies on use of medicinal marijuana. For further information pertaining to this article contact: United Cannabis Corporation at www.unitedcannabis.us.

Main Document

"The Doctors will establish evidence of cannabis-based medical efficacy, and create Intellectual Property (IP) on medically efficient cannabinoid-based products."

Recent appointees to a team of experts will explore the safety data required for Institutional Review Board (IRB) and FDA approval of human (Phase I, II, III) studies on the use of medicinal marijuana.

Brent A. Reynolds PhD, and Dennis A. Steindler PhD will focus on the Federal requirements necessary for approval to market medicinal marijuana drugs in legal communities.

As newly appointed Directors, Drs. Reynolds and Steindler will run and manage the Discovery Research & Development division of United Cannabis Corporation.

The Doctors will establish evidence of cannabis-based medical efficacy, and create Intellectual Property (IP) on medically efficient cannabinoid-based products.

Exploring the medical applications of cannabinoids, the Doctors will focus on IP claims, protecting products and their application, pre-clinical exploratory, proof of principal, and the safety data required for Institutional Review Board (IRB) and FDA approval of human (Phase I, II, III) studies on the use of medicinal marijuana.

  • Dr. Reynolds treats diseases and dysfunction of the nervous system.
  • Dr. Steindler diagnoses and treats neurodegenerative diseases and cancer.
  • Drs. Reynolds and Steindler have a record of patent protection and product development.

"Based on the evidence and efficacy of our programs, we are building a foundation established on human studies. United Cannabis will seek out the science behind full spectrum cannabinoids to develop synergistic medicine that compliments conventional therapies.

The Company now has an opportunity that not only allows us to research the plant, but with the recently appointed expert team of Drs. Reynolds and Steindler, we can convert those findings into realized products FDA approved for medical applications," notes Tony Verzura, VP United Cannabis Corporation.



Related Information:

  1. Marijuana has Potential for Autoimmune Disorders Treatment - University of South Carolina - (Nov 25, 2013)
    https://www.disabled-world.com/medical/pharmaceutical/marijuana/mirna-690.php
  2. Medical Marijuana Rated Much More Effective in Treating Fibromyalgia Symptoms Than Drugs - The National Pain Foundation - (Apr 21, 2014)
    https://www.disabled-world.com/health/fibromyalgia/rated.php
  3. Veterans with PTSD - Medical Marijuana Treatment Options - Thomas C. Weiss - (Feb 01, 2014)
    https://www.disabled-world.com/medical/pharmaceutical/marijuana/vet-marijuana.php

Information from our Medical Marijuana: Legalities & Health Condition Uses section - (Full List).


     What will I receive?

Loan Information for low income singles, families, seniors and disabled. Includes home, vehicle and personal loans.


Famous People with Disabilities - Well known people with disabilities and conditions who contributed to society.


List of awareness ribbon colors and their meaning. Also see our calendar of awareness dates.


Blood Pressure Chart - What should your blood pressure be. Also see information on blood group types and compatibility.


  1. Protein 3 Times Daily May Make Seniors Stronger
  2. Surgeons Practice Brain Surgery on 3D Printed Brain Models
  3. Comparison of Drug Cost Variation Between Drug Plans
  4. CP Awareness: World Cerebral Palsy Day Friday 6th October 2017




Citation